These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. [Pathophysiology of heart failure today]. Böhm M Herz; 2002 Mar; 27(2):75-91. PubMed ID: 12025466 [TBL] [Abstract][Full Text] [Related]
65. Pathophysiology of fluid retention in heart failure. Chaney E; Shaw A Contrib Nephrol; 2010; 164():46-53. PubMed ID: 20427993 [TBL] [Abstract][Full Text] [Related]
66. Peripheral factors in the management of congestive heart failure. Demopoulos L; LeJemtel TH Cardiovasc Drugs Ther; 1994 Feb; 8(1):75-82. PubMed ID: 8086331 [TBL] [Abstract][Full Text] [Related]
67. Pressor systems in hypertension and congestive heart failure. Role of vasopressin. Gavras H Hypertension; 1990 Nov; 16(5):587-93. PubMed ID: 2228158 [TBL] [Abstract][Full Text] [Related]
68. Compensatory and maladaptive responses to cardiac dysfunction. Francis GS; Chu C Curr Opin Cardiol; 1995 May; 10(3):260-7. PubMed ID: 7612975 [TBL] [Abstract][Full Text] [Related]
69. Pharmacological Treatment of Patients with Chronic Systolic Heart Failure. Maack C; Böhm M Eur Cardiol; 2014 Jul; 9(1):43-48. PubMed ID: 30310484 [TBL] [Abstract][Full Text] [Related]
70. Heart failure in 2001: a prophecy. Katz AM Am J Cardiol; 1992 Oct; 70(10):126C-131C. PubMed ID: 1414889 [TBL] [Abstract][Full Text] [Related]
71. Experimental hypervolemic heart failure; its bearing on certain general principles of heart failure. HUCKABEE W; CASTEN G; HARRISON TR Circulation; 1950 Mar; 1(3):343-56. PubMed ID: 15405703 [No Abstract] [Full Text] [Related]
72. N-terminal pro-B-type natriuretic peptide for prediction of ventricular arrhythmias: Data from the SMASH study. Sourour N; Riveland E; Naesgaard P; Kjekshus H; Larsen AI; Omland T; Røsjø H; Myhre PL Clin Cardiol; 2023 Aug; 46(8):989-996. PubMed ID: 37400982 [TBL] [Abstract][Full Text] [Related]
73. The three integrated phases of left atrial macrophysiology and their interactions. Mehrzad R; Rajab M; Spodick DH Int J Mol Sci; 2014 Aug; 15(9):15146-60. PubMed ID: 25167138 [TBL] [Abstract][Full Text] [Related]
75. A risk-benefit assessment of ACE inhibitor therapy post-myocardial infarction. Borghi C; Ambrosioni E Drug Saf; 1996 May; 14(5):277-87. PubMed ID: 8800625 [TBL] [Abstract][Full Text] [Related]
76. Effects of mild mitral valve insufficiency, sodium intake, and place of blood sampling on the renin-angiotensin system in dogs. Pedersen HD Acta Vet Scand; 1996; 37(1):109-18. PubMed ID: 8659339 [TBL] [Abstract][Full Text] [Related]
77. The treatment of heart failure--what next? Davies RH; Sheridan DJ Br J Clin Pharmacol; 1993 Jun; 35(6):557-63. PubMed ID: 8329279 [TBL] [Abstract][Full Text] [Related]
78. Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials. Young JB Cardiovasc Drugs Ther; 1995 Feb; 9(1):89-102. PubMed ID: 7786840 [TBL] [Abstract][Full Text] [Related]
79. Neuroendocrine activity in congestive heart failure. Francis GS Am J Cardiol; 1990 Oct; 66(11):33D-38D; discussion 38D-39D. PubMed ID: 2220603 [TBL] [Abstract][Full Text] [Related]
80. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Francis GS; Benedict C; Johnstone DE; Kirlin PC; Nicklas J; Liang CS; Kubo SH; Rudin-Toretsky E; Yusuf S Circulation; 1990 Nov; 82(5):1724-9. PubMed ID: 2146040 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]